Page 753 - Coronavirus Vaccine

DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India

Dr Reddy's Laboratories and Russian Direct Investment Fund (RDIF) on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India. The trials have commenced after receiving the necessary clearance from the Kasauli-based Central Drugs Laboratory, they added. This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study, the Hyderabad-based drug maker and RDIF said in a joint statement. The clinical trials are being conducted by JSS Medical Research as the clinical research partner. Further, Dr Reddy's has partnered with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT) for advisory support and to use BIRAC's clinical trial centres for the vaccine, it added. Recently, RDIF had announced the second interim analysis of clinical trial data, which showed 91.4 per cent efficacy for the vaccine on day 28 after the first dose; and efficacy of o

Adverse event in Serum's trial won't affect vaccine timelines: Health secy

Health ministry to come out with guidelines that will address the issues around vaccine safety to create awareness and dispel misinformation

Coronavirus LIVE: Phase 2/3 trials of Sputnik V vaccine starts in India

Coronavirus LIVE update: At 1,828,826, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 884,897, Andhra Pradesh 868,064, Tamil Nadu 781,915 and Kerala 602,982

S&P 500, Nasdaq start December at peak on Covid-19 vaccine optimism

(Reuters) - The S&P 500 and the Nasdaq hit record highs on Tuesday as hopes that a COVID-19 vaccine will be available soon and better-than-expected factory data from China bolstered bets of a speedy economic recovery.

Covid vaccine won't be released unless proven safe, assures Serum Institute

SII says after DSMB and ethics committee cleared they continued with the trials; sympathetic with the condition of the subject

AstraZeneca partner sticks with 2 full dose regimen in India Covid trials

The British drugmaker has said its COVID-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose

We never mentioned we'd vaccinate entire population, says Health ministry

However, Bhushan stated that it is the responsibility of the Union and the state government to allay fears among the people regarding the vaccine

Findings into 'adverse event' at Serum didn't require halting trial: Govt

The Pune-based vaccine manufacturer on Tuesday said that the vaccine is safe and immunogenic

Cabinet Secy discusses with states possible Covid-19 vaccine roll-out

Cabinet Secretary Rajiv Gauba on Tuesday reviewed with top officials of states the arrangements for the roll-out of vaccines after these are available and asked them to prepare a database of people

Pfizer-BioNTech apply for EU emergency authorisation for Covid-19 vaccine

The application to the European Medicines Agency (EMA) comes after the companies applied for US approval on Nov. 20, taking them a step closer to launching their vaccine.

India Coronavirus Dispatch: How emergency vaccine authorisation works

Queues at Ahmedabad's crematoriums get longer, doubts about AstraZeneca vaccine and bringing diagnostics closer to communities-news relevant to India's fight against Covid-19

China gave Covid-19 vaccine candidate to North Korea's Kim: US analyst

North Korea has not confirmed any coronavirus infections, South Korea has said an outbreak there cannot be ruled out.

World Coronavirus Dispatch: Unrest in Sri Lanka's cramped prisons

Pandemic widens regional rich-poor gap in Russia, China seeks to change Covid origin story, Food delivery workers are struggling, and other pandemic-related news across the globe

Covid-19 Factoid: India records a drop of 11,000 in active cases in a day

Delhi witnessing a drop in new cases while West Bengal adds less than 3,000 cases in a day for the first time in 3 months

Covid-19 resurgence poses challenges to economic recovery: Fed chief Powell

US Federal Reserve Chairman Jerome Powell said that the continuing Covid-19 resurgence across the country could pose challenges to the economic recovery in the next few months

Top headlines: Jet to resume all services in 2021; DFI tag for IIFCL

From Jet Airways planning to resume all services in 2021 to FinMin proposing DFI tag for IIFCL, here are top headlines this morning

Coronavirus vaccine update: Serum vs volunteer fight, PM calls meet, & more

Listen to the podcast to know all the key updates related to vaccine

COVID-19 caseload in India rises to 9.4 million, death toll at 1,37,621

The recoveries surged to 88,89,585, according to the Union Health Ministry's data updated on Tuesday.

Brazil registers 287 new Covid-19 fatalities, toll now at over 173,000

Brazil registered 21,138 new infections and 287 new deaths from Covid-19 in the past 24 hours, raising its national caseload to 6,335,878 and death toll to 173,120

Hospitalisations of coronavirus patients hit an all-time high in US

Hospitalisation of coronavirus infected patients in the US have reached an all-time high as the country is witnessing an ongoing resurgence of new confirmed cases